| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |